GENEVA, Sept. 18 -- THERANOCURE CO., LTD. filed a patent application (KR2026/003606) for “VANILLIC ACID DERIVATIVE COMPOUND, THERAPEUTIC AGENT COMPOSITION FOR ALZHEIMER'S DISEASE COMPRISING SAME, AND THERAPEUTIC AGENT COMPOSITION FOR NEUROINFLAMMATORY DISEASE”. With publication no. WO/2026/187186, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07C 235/48
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....